The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo
Clicks: 295
ID: 268330
2002
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
295 views
35 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #2 of 14 articles by views in Journal of Clinical Investigation
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Vitiligo is a common depigmenting disorder resulting from the loss of melanocytes in the skin. The pathogenesis of the disease remains obscure, although autoimmune mechanisms are thought to be involved. Indeed, autoantibodies and autoreactive T lymphocytes that target melanocytes have been reported in some vitiligo patients. The objective of this study was to identify pigment cell antigens that are recognized by autoantibodies in vitiligo. Using IgG from vitiligo patients to screen a melanocyte cDNA phage-display library, we identified the melanin-concentrating hormone receptor 1 (MCHR1) as a novel autoantigen related to this disorder. Immunoreactivity against the receptor was demonstrated in vitiligo patient sera by using radiobinding assays. Among sera from healthy controls and from patients with autoimmune disease, none exhibited immunoreactivity to MCHR1, indicating a high disease specificity for Ab's against the receptor. Inhibition of MCH binding to its receptor by IgG from vitiligo patients was also shown.
| Reference Key |
watson2002journalthe
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | E. Helen Kemp,Elizabeth A. Waterman,Brian E. Hawes,Kim O’Neill,Raju V.S.R.K. Gottumukkala,David J. Gawkrodger,Anthony P. Weetman,Philip F. Watson;E. Helen Kemp;Elizabeth A. Waterman;Brian E. Hawes;Kim O’Neill;Raju V.S.R.K. Gottumukkala;David J. Gawkrodger;Anthony P. Weetman;Philip F. Watson; |
| Journal | Journal of Clinical Investigation |
| Year | 2002 |
| DOI |
10.1172/jci14643
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.